Trionfo Research has a longstanding presence in India, with extensive experience working in both urban and rural areas of the country. With access to more than 500 sites and a population of 1.4 billion, including a large treatment-naïve population and lower clinical development costs compared to Western countries, India stands out as an ideal destination for conducting clinical trials. Additionally, many sites in India boast state-of-the-art facilities and well-trained clinical research professionals with excellent English language skills.
India's regulatory environment has undergone significant improvements in recent years, particularly with the formalization of the New Drugs Clinical Trial Rules (NDCT) in 2019. These regulations have been well received by the global research community for their balance and clarity. Furthermore, many sites in India have extensive experience in conducting international clinical trials and are well-versed in the requirements involved. The fact that these sites have been inspected by regulatory agencies such as the USFDA, MHRA, and EMEA in the past demonstrates their ability to conduct quality clinical trials that meet international standards. Overall, these factors make India an extremely attractive destination for conducting clinical trials for Trionfo Research.
Address
406, 4th Floor, Tower B Ithum Tower, Sector 62, Noida 201301
Call
+91 83759 79979